Abstract
Objective: To evaluate the role of exponential apparent diffusion coefficient (ADC) as a tool
for differentiating benign and malignant breast lesions. Patients and Methods: This
prospective observational study included 88 breast lesions in 77 patients (between
18 and 85 years of age) who underwent 3T breast magnetic resonance imaging (MRI) including
diffusion-weighted imaging (DWI) using b-values of 0 and 800 s/mm2 before biopsy.
Mean exponential ADC and ADC of benign and malignant lesions obtained from DWI were
compared. Receiver operating characteristics (ROC) curve analysis was undertaken to
identify any cut-off for exponential ADC and ADC to predict malignancy. P value of <0.05 was considered statistically significant. Histopathology was taken
as the gold standard. Results: According to histopathology, 65 lesions were malignant and 23 were benign. The mean
ADC and exponential ADC values of malignant lesions were 0.9526 ± 0.203 × 10−3 mm2/s
and 0.4774 ± 0.071, respectively, and for benign lesions were 1.48 ± 0.4903 × 10−3
mm2/s and 0.317 ± 0.1152, respectively. For both the parameters, differences were
highly significant (P < 0.001). Cut-off value of ≤0.0011 mm2/s (P < 0.0001) for ADC provided 92.3% sensitivity and 73.9% specificity, whereas with
an exponential ADC cut-off value of >0.4 (P < 0.0001) for malignant lesions, 93.9% sensitivity and 82.6% specificity was obtained.
The performance of ADC and exponential ADC in distinguishing benign and malignant
breast lesions based on respective cut-offs was comparable (P = 0.109). Conclusion: Exponential ADC can be used as a quantitative adjunct tool for characterizing breast
lesions with comparable sensitivity and specificity as that of ADC.
Keywords
Apparent diffusion coefficient - breast MRI - diffusion-weighted imaging - exponential
apparent diffusion coefficient